People · Operator

David W. Karp, M.D.

Named in public records as an officer, director or promoter · Hospitals and Physicians

1
Companies
1
Filings
$154K
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Arc Kentucky LlcHospitals and PhysiciansPre-Seed$154K$252K
Operator network

David W. Karp, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Teresa F. Sparks · 30 companies · 1 sharedTeresa F. SparksClifford G. Adlerz · 25 companies · 1 sharedClifford G. AdlerzKenneth C. Mitchell · 25 companies · 1 sharedKenneth C. Mitche…Jennifer B. Baldock · 24 companies · 1 sharedJennifer B. Baldo…Ronald L. Brank · 24 companies · 1 sharedRonald L. Brank. Symbion Holdings Corporation · 19 companies · 1 shared. Symbion Holding…Anthony W. Taparo · 13 companies · 1 sharedAnthony W. TaparoDarrel L. Naish · 13 companies · 1 sharedDarrel L. NaishGeorge M. Goodwin · 9 companies · 1 sharedGeorge M. Goodwin. ARC Financial Services Corporation · 4 companies · 1 shared. ARC Financial S…John W. Morris, M.D. · 1 companies · 1 sharedJohn W. Morris, M…Preston W. Bain · 1 companies · 1 sharedPreston W. BainArc Kentucky Llc · $0.2M raisedArc Kentucky LlcDavid W. Karp, M.D.DM
David W. Karp, M.D. Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David W. Karp, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Teresa F. Sparks130
Clifford G. Adlerz125
Kenneth C. Mitchell125
Ronald L. Brank124
Jennifer B. Baldock124
. Symbion Holdings Corporation119
Darrel L. Naish113
Anthony W. Taparo113
George M. Goodwin19
. ARC Financial Services Corporation14
Preston W. Bain11
John W. Morris, M.D.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.